Revive Therapeutics $RVVTF

Amazing Sales of Paxlovid (CBS News).

"These medicines have a sweet spot. If the day you get diagnosed COVID you say 'forget it, I'll be fine,' and then...
Dyadic, Biotech Stock Review

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.

SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the COVID-19 Pandemic.

FOR IMMEDIATE RELEASE2020-131 Washington D.C., June 11, 2020 — The Securities and...

VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...

Internet Stock Review Blast from the past scores big! We added VirnetX (VHC)...

MRSA: Can Kill Within 24 Hours. Here Are Some Basics.

RESIST THE RESISTANCE: A PRIMER ON ANTIBIOTICS & ANTIBIOTIC RESISTANCE (2013) I was going to write this week about...

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Aphex BioCleanse Systems Welcomes Original Shark Tank Investor Kevin Harrington and World-Renowned Entrepreneur Mark Timm as Advisors
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...